Basic research on development of dendritic cell therapy targeting glioma cancer stem cells
Project/Area Number |
15K10346
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Neurosurgery
|
Research Institution | Kansai Medical University |
Principal Investigator |
ASAI Akio 関西医科大学, 医学部, 教授 (50231858)
|
Co-Investigator(Kenkyū-buntansha) |
岩田 亮一 関西医科大学, 医学部, 助教 (60580446)
伊藤 量基 関西医科大学, 医学部, 准教授 (70434826)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | グリオーマ / 膠芽腫 / 癌幹細胞 / 樹状細胞 / 免疫抑制 / 免疫治療 / テモゾロミド / がん幹細胞 |
Outline of Final Research Achievements |
Glioblastoma multiforme (GBM) is the most fatal malignant primary brain tumor. GBM contains functional subsets of cells called glioblastoma stem-like cells (GSCs), which are radioresistant and chemoresistant and eventually lead to tumor recurrence. We established GSCs lines and analyzed the expression of immune-associated molecules. GSCs lines were positive for MHC-Ⅰ, which indicated that GSCs can be recognized by T cells. Temozolomide (TMZ) is an oral alkylating agent with established anti-tumor activity in patients with GBM. We focused on the TMZ function and explored its influence on human dendritic cells (DCs) subsets. TMZ suppressed the secretion of IL-10 from DCs. Moreover, the addition of TMZ into peripheral blood mononuclear cells with DCs significantly enhanced the DC mediated ex vivo expansion and expression of cytotoxic molecules in CD8+ T cells. Our present findings suggest that TMZ is a potential anti-tumor reagent suitable for the combination use with DC-vaccine therapy.
|
Report
(4 results)
Research Products
(32 results)
-
-
-
-
-
[Journal Article] Establishment of a tumor sphere cell line from a metastatic brain neuroendocrine tumor.2017
Author(s)
Iwata R, Maruyama M, Ito T, Nakano Y, Kanemura Y, Koike T, Oe S, Yoshimura K, Nonaka M, Nomura S, Sugimoto T, Yamada H, Asai A.
-
Journal Title
Med Mol Morphol
Volume: 50(4)
Issue: 4
Pages: 211-219
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
[Journal Article] Serine/Threonine kinase MLK4 determines Mesenchymal Identity in Glioma Stem Cells in an NFkB-dependent manner2016
Author(s)
Kim SH, Ezhilarasan R, Chhipa R, Ladner K, Phillips E, Sparks A, Taylor D, Furuta T, Sabit H, Kurozumi K, Kuroiwa T, Akio A, Gallego-Perez1 D, Sulman EP, Cheng S, Lee J, Nakada M, Guttridge D, DasGupta B, Goidts V, Bhat KP, Walker J, Nakano I.
-
Journal Title
Cancer Cell
Volume: 29
Issue: 2
Pages: 201-213
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
-
-
-
-
-
-
-
-
-
-
-
[Presentation] 神経内分泌腫瘍の転移脳組織からの癌幹細胞2017
Author(s)
岩田亮一, 丸山正人, 伊藤量基, 中野洋輔, 小池太郎, 大江聡一, 吉村晋一, 埜中正博, 野村昌作, 杉本哲夫, 山田久夫, 淺井昭雄
Organizer
第49回日本臨床分子形態学会総会・学術集会
Related Report
-
-
-
[Presentation] Effect of Temozolomide on Brain Metastasis of neuroendocrine carcinoma.2016
Author(s)
Ryoichi Iwata, Masato Maruyama, Tomoki Ito, Yoko Fujita, Yoshiyuki Matsuo, Yosuke Nakano, Kunikazu Yoshimura, Masahiro Nonaka, Kiichi Hirota, Shosaku Nomura, Tetsuo Sugimoto, Akio Asai.
Organizer
The 13th Asian Society for Neuro-oncology (ASNO) Meeting.
Place of Presentation
Sheraton on the Park, Sydney, Australia
Year and Date
2016-09-11
Related Report
Int'l Joint Research
-
-
[Presentation] グリオーマ癌幹細胞で発現するICOSリガンドを介した免疫制御機構の新展開2015
Author(s)
岩田亮一, 伊藤量基, 稲葉宗夫, 小池太郎, 二宮英樹, 李一, 染野裕美子, 亀井孝昌, 武田純一, 大石哲也, 大重英行, 吉村晋一, 埜中正博, 山田久夫, 野村昌作, 中野伊知郎, 淺井昭雄
Organizer
第33回日本脳腫瘍学会学術集会
Place of Presentation
京都府京都市左京区宝ヶ池グランドプリンスホテル京都
Year and Date
2015-12-06
Related Report
-
[Presentation] Mesenchymal type Glioma Stem Cell express ICOS Ligand and upregulate Tr1 cells2015
Author(s)
Ryoichi Iwata, Tomoki Ito, Muneo Inaba, Taro Koike, Hideyuki Oshige, Kunikazu Yoshimura, Masahiro Nonaka, Hisao Yamada, Shosaku Nomura, Umberto Dianzani, Ichiro Nakano, Akio Asai
Organizer
the 20th Annual Scientific Meeting and Education Day of the Society for Neuro-Onclology
Place of Presentation
San Antonio,Texas, USA San Antonio Marriott Rivercenter
Year and Date
2015-11-19
Related Report
Int'l Joint Research
-
[Presentation] Mesenchymal type Glioma Stem Cell express ICOS Ligand and upregulate ICOS+IL-10+Tcells2015
Author(s)
岩田亮一, 伊藤量基, 稲葉宗夫, 小池太郎, 大重英行, 吉村晋一, 埜中正博, 山田久夫, 野村昌作, 中野伊知郎, 淺井昭雄
Organizer
第56回日本組織細胞化学会総会・学術集会
Place of Presentation
大阪府枚方市新町関西医科大学枚方新キャンパス
Year and Date
2015-10-03
Related Report
-
[Presentation] Therapeutical dose of Temozolomide inhibit IL-10 production by dendritic cells and enhance the CTL response2015
Author(s)
Ryoichi Iwata, Tomoki Ito, Muneo Inaba, Noriko Katashiba, Kayoko Kibata, Akihiro Tanaka, Phan Thi Xuan Vien, Hideyuki Oshige, Kunikazu Yoshimura, Takehiro Suyama, Masahiro Nonaka, Shosaku Nomura, Akio Asai
Organizer
ASNO 2015 12th Meeting of the Asian Society for Neuro-Onclology
Place of Presentation
Pasay City Manila, Philippines Sofitel Philippine Plaza Hotel
Year and Date
2015-09-17
Related Report
Int'l Joint Research
-
[Presentation] Mesenchymal typeのグリーマ癌幹細胞で発現するICOSリガンドは、IL-10産生T細胞を誘導する2015
Author(s)
岩田亮一, 伊藤量基, 稲葉宗夫, 小池太郎, 大重英行, 吉村晋一, 埜中正博, 山田久夫, 野村昌作, 中野伊知郎, 淺井昭雄
Organizer
第25回日本サイトメトリー学会学術集会
Place of Presentation
東京都千代田区神田駿河台ソラシティカンファレンスセンター
Year and Date
2015-07-11
Related Report
-
-
-